Checked.be
Active
BE 0472.711.583Private limited company
ARIA - DOC
Visvijverstraat 112 ·1050 Elsene, Belgium· 25 yrs active
Sector: General medical practice
(86210)
Conclusion
ARIA - DOC has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €154k and a net result of €23k. Equity is shrinking by ~5.4% per year across the filed fiscal years. Its solvency ranks better than 65% of 2244 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Based on the State Gazette, CBE and 5 annual accounts.
Key figures
| Equity | €154k |
| Net result | €23k |
| Staff (FTE) | 2 |
| Better than sector | 65% |
Financial profile
79
/ 100
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Health
100
Profitability
74
Solvency
89
Growth
32
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
Long-established
Founded in 2000, 26 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
100
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€15k
estimate, not credit advice
Score history
93
2021
85
2022
88
2023
58
2024
100
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 1.50 (≥ 1.5)
+10
Quick ratio
Quick ratio 1.50 (≥ 1.0)
+5
Leverage
Debt/equity 0.32 (< 1.0)
+10
Profitability
ROE 15% (≥ 10%)
+10
Interest coverage
Interest coverage 21.9× (≥ 3×)
+8
Profit trend
Net profit up YoY
+5
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 06-07-2026 with the NBB · fiscal year 2025 · abbreviated schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
declining
Equity: declining trend of ~5.4%/year over 5 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (abbreviated schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 75.7% | 59.8% | |
| Net result | €23k | €121k | |
| Equity | €154k | €395k | |
| Gross operating margin | €90k | €301k | |
| Staff costs | €28k | €111k |
€60k
+53.6%
21-25
€23k
+173.8%
21-25
€47k
+41.1%
21-25
€203k
-9.2%
21-25
€154k
+1.2%
21-25
€25k
-
21-25
2
0.0%
21-25
€28k
-5.5%
21-25
€11k
+198.0%
21-25
€21k
-23.0%
21-25
€49k
-31.2%
21-25
€49k
-31.2%
21-25
€14k
-55.0%
21-25
1.50
+52.0%
21-25
1.50
+52.0%
21-25
75.7%
+11.4%
21-25
0.32
-32.0%
21-25
14.8%
+170.5%
21-25
11.2%
+201.4%
21-25
21.93
+45.7%
21-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | abbreviated schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €60k | €39k | €58k | €99k | €131k |
| Net profit | €23k | €8k | €22k | €54k | €83k |
| Cash flow | €47k | €33k | €47k | €77k | €100k |
| Staff costs | €28k | €29k | €20k | €17k | €19k |
| Income taxes | €11k | €4k | €9k | €20k | €29k |
| Dividends | €21k | €27k | €10k | €84k | €18k |
| Total assets | €203k | €224k | €256k | €306k | €315k |
| Equity | €154k | €152k | €171k | €159k | €189k |
| Debt | €49k | €72k | €85k | €147k | €127k |
| of which ≤ 1y | €49k | €72k | €71k | €117k | €73k |
| of which > 1y | - | - | €14k | €30k | €54k |
| Working capital | €25k | €-903 | €7k | €4k | €41k |
| Employees (FTE) | 2.0 | 2.0 | 1.5 | 1.8 | 2.0 |
Note: these years are not on the same basis. The filed schemas differ (abbreviated schema, micro schema), so the columns are not directly comparable.
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 1.50 | 0.99 | 1.10 | 1.04 | 1.57 |
| Quick ratio | 1.50 | 0.99 | 1.10 | 1.04 | 1.57 |
| Working capital ratio | 12.1% | -0.4% | 2.7% | 1.4% | 13.1% |
| Solvency | 75.7% | 68.0% | 66.8% | 52.0% | 59.9% |
| Debt / equity | 0.32 | 0.47 | 0.50 | 0.92 | 0.67 |
| Long-term debt ratio | - | - | 0.08 | 0.19 | 0.28 |
| Interest coverage | 21.93 | 15.05 | 23.42 | 38.11 | 69.99 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 11.2% | 3.7% | 8.5% | 17.7% | 26.2% |
| ROE | 14.8% | 5.5% | 12.7% | 34.0% | 43.7% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Balance-sheet composition 2025
Full annual accounts (23 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €203k | €224k | €256k | €306k | €315k |
| Fixed assets | 21/28 | €129k | €153k | €178k | €185k | €201k |
| Tangible fixed assets | 22/27 | €129k | €153k | €178k | €185k | €201k |
| Current assets | 29/58 | €74k | €71k | €78k | €121k | €114k |
| Amounts receivable within one year | 40/41 | €13k | €12k | €15k | - | - |
| Cash & bank | 54/58 | €59k | €48k | €61k | €115k | €110k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €203k | €224k | €256k | €306k | €315k |
| Equity | 10/15 | €154k | €152k | €171k | €159k | €189k |
| Contributions / capital | 10/11 | €20k | €20k | €19k | €19k | €19k |
| Reserves | 13 | €190k | €188k | €208k | €196k | €226k |
| Accumulated profits (losses) | 14 | €-56k | €-56k | €-56k | €-56k | €-56k |
| Amounts payable | 17/49 | €49k | €72k | €85k | €147k | €127k |
| Amounts payable after one year | 17 | - | - | €14k | €30k | €54k |
| Amounts payable within one year | 42/48 | €49k | €72k | €71k | €117k | €73k |
| Trade debts payable within one year | 44 | €1k | €2k | €1,000 | €8k | - |
| Income statement | ||||||
| Gross operating margin | 9900 | €90k | €71k | €81k | €119k | €153k |
| Operating result | 9901 | €36k | €15k | €33k | €76k | €114k |
| Financial income | 75 | €193 | €143 | - | - | - |
| Financial charges | 65 | €3k | €3k | €2k | €3k | €2k |
| Result before taxes | 9903 | €34k | €12k | €30k | €74k | €112k |
| Income taxes | 67/77 | €11k | €4k | €9k | €20k | €29k |
| Net result for the period | 9904 | €23k | €8k | €22k | €54k | €83k |
| Result to be appropriated | 9905 | €23k | €8k | €22k | €54k | €83k |
Directors & mandates
Current directors & mandates
-
SAFFARIAN TOUSI MajidDirectorState Gazette act 23481920 (28-12-2023)Current28-12-2023 → present
2 events
- 28-12-2023 Resigned· Gérant
- 28-12-2023 Appointed· Director
Legal Structure
| NACE primary | General medical practice(86210) |
| Legal form | Private limited company(610) |
| Incorporation | 08-09-2000 |
| Status | Active |
| Postal code | 1050 |
Establishment units
Visvijverstraat 112, 1050 Elsene
since 20002.227.922.031
Hertogin van Brabantplaats 40, 1080 Sint-Jans-Molenbeek
since 20062.227.922.427
Leuvensesteenweg 281, 1030 Schaarbeek
since 20072.227.922.724
Real-estate footprint
Brussels
3
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21523B0937/00W088 | Brussels | 218 m² | 1 · 217 m² | 14.8 m · 4 fl. |
| 21906D0072/00L011 | Brussels | 130 m² | 1 · 72 m² | 18.4 m · 5 fl. |
| 21443A0095/00M004 | Brussels | 98 m² | 1 · 77 m² | 12.4 m · 3 fl. |
Methodology
via registered seat: 1 · via establishment units: 2
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
06-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
07-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 7 days late
2024
31-12
Financial
Weakest financial yearnet €8k ▼61.4%
Net result drops to €8k, the lowest in the series; recovery starts the following year.
08-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 8 days late
2023
28-12
State Gazette act
Director changes
v3.2
26-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
24-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
20-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 20 days late
2020
26-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 26 days late
2019
31-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
28-09
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 59 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 31 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Belgisch Staatsblad, acts
All acts · 1
updated 2 years ago
2023
28-12-2023 1 director appointed, 1 resigning
- SAFFARIAN TOUSI Majid, Bestuurder
- SAFFARIAN TOUSI Majid, Gérant
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "SAFFARIAN TOUSI Majid",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SAFFARIAN TOUSI Majid",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0472.711.583",
"name_full": "ARIA - DOC"
}
}Credit advice
Company registry (CBE)
Activities
85120General medical practice86210
Names & trade names
| Legal nameFR | ARIA - DOC |
Similar companies
Dokter Silvie Bloemen
BE 0882.536.781 · Berlaar
Dr. Hans Antonneau
BE 0812.272.357 · Antwerpen
Docteur B
BE 0803.606.990 · Brussel
Platteau Lut Huisarts
BE 0776.943.967 · Hasselt
DR. TINE HUYGHE
BE 0778.965.428 · Koksijde